Soleno Therapeutics (SLNO) had the highest return between July 21, 2023 and January 5, 2024 by a US stock with a market cap of $2B+, returning 632.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 7/21/2023 - 1/5/2024 | 632.74% |
QXO (QXO) | 7/21/2023 - 1/5/2024 | 601.11% |
Cytokinetics (CYTK) | 7/21/2023 - 1/5/2024 | 188.76% |
Affirm (AFRM) | 7/21/2023 - 1/5/2024 | 147.9% |
Abercrombie & Fitch (ANF) | 7/21/2023 - 1/5/2024 | 147.58% |
Telephone and Data Systems (TDS) | 7/21/2023 - 1/5/2024 | 136.83% |
United States Cellular (USM) | 7/21/2023 - 1/5/2024 | 135.53% |
Gap (GAP) | 7/21/2023 - 1/5/2024 | 129.83% |
Scholar Rock (SRRK) | 7/21/2023 - 1/5/2024 | 128.94% |
Rhythm Pharmaceuticals (RYTM) | 7/21/2023 - 1/5/2024 | 127.66% |
Alpha Metallurgical Resources (AMR) | 7/21/2023 - 1/5/2024 | 123.78% |
TAL Education (TAL) | 7/21/2023 - 1/5/2024 | 105.53% |
Compania de Minas Buenaventura SAA ADR (BVN) | 7/21/2023 - 1/5/2024 | 105.34% |
United States Steel (X) | 7/21/2023 - 1/5/2024 | 96.76% |
Uranium Energy (UEC) | 7/21/2023 - 1/5/2024 | 96.02% |
PDD (PDD) | 7/21/2023 - 1/5/2024 | 91.89% |
Globalstar, Inc Common Stock (GSAT) | 7/21/2023 - 1/5/2024 | 89.72% |
Immunovant (IMVT) | 7/21/2023 - 1/5/2024 | 85.44% |
Pactiv Evergreen (PTVE) | 7/21/2023 - 1/5/2024 | 77.91% |
Flex (FLEX) | 7/21/2023 - 1/5/2024 | 77.44% |
Vertiv (VRT) | 7/21/2023 - 1/5/2024 | 75.31% |
Crinetics Pharmaceuticals (CRNX) | 7/21/2023 - 1/5/2024 | 72.76% |
Celestica (CLS) | 7/21/2023 - 1/5/2024 | 72.07% |
Apellis Pharmaceuticals (APLS) | 7/21/2023 - 1/5/2024 | 71.44% |
BW LPG (BWLP) | 7/21/2023 - 1/5/2024 | 70.65% |
